These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6146376

  • 1. Sulphasalazine in rheumatoid arthritis.
    Crisp AJ.
    Br J Rheumatol; 1984 Aug; 23(3):232. PubMed ID: 6146376
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sulphasalazine-induced systemic lupus erythematosus.
    Mongey AB, Hess EV.
    Br J Rheumatol; 1994 Aug; 33(8):789-90. PubMed ID: 7914458
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA, Davis MJ, Dawes PT, Shadforth MF.
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [Abstract] [Full Text] [Related]

  • 9. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA.
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M, Dromer C, Andrieu V, Le Guennec P, Fournie B.
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acetylation, sulphasalazine and its effects.
    Astbury C, Taggart AJ.
    Br J Rheumatol; 1987 Jun; 26(3):229-30. PubMed ID: 2884010
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA, Pullar T, Hunter JA.
    Drugs; 1986 Jun; 32 Suppl 1():44-8. PubMed ID: 2877852
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sulfasalazine-induced lupus erythematosus.
    Clementz GL, Dolin BJ.
    Am J Med; 1988 Mar; 84(3 Pt 1):535-8. PubMed ID: 2894766
    [Abstract] [Full Text] [Related]

  • 18. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
    Gunnarsson I, Nordmark B, Hassan Bakri A, Gröndal G, Larsson P, Forslid J, Klareskog L, Ringertz B.
    Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
    [Abstract] [Full Text] [Related]

  • 19. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM, Porter DR, Capell HA.
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [Abstract] [Full Text] [Related]

  • 20. Sulfasalazine induced seizures and dysphasia.
    Hill ME, Gordon C, Situnayake RD, Heath DA.
    J Rheumatol; 1994 Apr; 21(4):748-9. PubMed ID: 7913503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.